Delivery Order SPE2DR25D7059-SPE2DR26F7NPY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,113.16 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this work at its corporate office location. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $2,856.60 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 15, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively on January 14, 2026. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,020.91 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $2,223.26 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, a topical pain management pharmaceutical product. This non-compete, firm fixed-price delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,188.58 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 12, 2026, and was competitively awarded without a set-aside designation. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,921.84 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 7, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $5,336.70. This firm fixed-price delivery order is not set aside and is scheduled for ultimate completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 5, 2025, for the supply of Lidocaine 5% Patch 30s. This competitively awarded, non-set-aside contract has a ceiling value of $9,486.98 with firm fixed pricing and an ultimate completion date of November 6, 2025. The delivery order is executed under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 13, 2026, by the Defense Logistics Agency (DLA) for Lidocaine 5% Patch 30s with a ceiling value of $2,390.40. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 14, 2026, and no set-aside designation was applied. This award was issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7NPYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,841.80 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units, with an ultimate completion date of January 15, 2026. This contract was competitively awarded on January 14, 2026, with no set-aside designation, and represents a firm fixed-price delivery order to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order falls under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The parent company, Cencora, Inc., also maintains a separate IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, demonstrating the strategic importance of this vendor to federal medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/13/26 |